| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphodiesterase 4A | 0.523 | 0.846 | 0.98 |
|
disease | 0.370 | None | 1.000 | 5 | 0 | 2007 | 2019 | ||||||||
|
hypocretin neuropeptide precursor | 0.500 | 0.808 | 2.9E-02 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2009 | 2020 | ||||||||
|
galanin and GMAP prepropeptide | 0.493 | 0.846 | 4.4E-06 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2006 | 2019 | ||||||||
|
purinergic receptor P2X 7 | 0.450 | 0.808 | 3.3E-11 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2006 | 2019 | ||||||||
|
oxytocin receptor | 0.541 | 0.769 | 7.1E-04 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2008 | 2019 | ||||||||
|
oxytocin/neurophysin I prepropeptide | 0.615 | 0.423 | 0.71 |
|
disease | 0.310 | None | 1.000 | 5 | 0 | 2012 | 2014 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1999 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
disease | 0.360 | None | 1.000 | 5 | 0 | 2006 | 2017 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2001 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2011 | 2020 | ||||||||
|
transthyretin | 0.423 | 0.885 | 0.52 |
|
disease | 0.320 | None | 1.000 | 5 | 0 | 1985 | 2018 | ||||||||
|
calmodulin 2 | 0.472 | 0.808 | 0.92 |
|
disease | 0.310 | None | 0.800 | 5 | 0 | 2005 | 2014 | ||||||||
|
tachykinin precursor 1 | 0.424 | 0.923 | 0.75 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1999 | 2020 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.380 | None | 0.800 | 5 | 0 | 2010 | 2019 | ||||||||
|
tachykinin receptor 1 | 0.502 | 0.885 | 3.8E-04 |
|
disease | 0.320 | None | 0.800 | 5 | 0 | 2003 | 2018 | ||||||||
|
tyrosine hydroxylase | 0.462 | 0.885 | 1.7E-06 |
|
disease | 0.320 | None | 0.800 | 5 | 0 | 2000 | 2014 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2002 | 2020 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1996 | 2020 | ||||||||
|
TNF receptor superfamily member 1A | 0.409 | 0.923 | 0.99 |
|
disease | 0.360 | None | 0.800 | 5 | 0 | 2006 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2005 | 2019 | ||||||||
|
cannabinoid receptor 2 | 0.509 | 0.846 | 6.5E-06 |
|
disease | 0.550 | None | 1.000 | 5 | 0 | 2006 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2009 | 2020 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.500 | None | 1.000 | 5 | 0 | 1983 | 2019 | ||||||||
|
cAMP responsive element binding protein 1 | 0.463 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2002 | 2019 | ||||||||
|
thyrotropin releasing hormone | 0.519 | 0.846 | 8.9E-04 |
|
disease | 0.330 | None | 1.000 | 5 | 0 | 1983 | 2014 |